Responses
Immunotherapy biomarkers
Original research
Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade
Compose a Response to This Article
Other responses
No responses have been published for this article.
